Sign in
Hijacking of GABAA Receptors by Mutant Glycine Receptors
Journal article   Peer reviewed

Hijacking of GABAA Receptors by Mutant Glycine Receptors

Robert J Harvey
Trends in Molecular Medicine, Vol.25(10), pp.823-825
2019
url
https://doi.org/10.1016/j.molmed.2019.08.010View
Published Version

Abstract

benzodiazepines glycine receptors GABAA receptors GlyT2 hyperekplexia startle disease
Startle disease results from mutations in genes encoding inhibitory GlyR α1 and β subunits or the presynaptic glycine transporter GlyT2. However, the most effective therapies are benzodiazepines that potentiate inhibitory GABAAR function. A recent publication by Zou et al. adds further complexity by suggesting that dominant GlyR α1 mutants assemble into pre- and extrasynaptic GABAARs.

Details

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Web Of Science research areas
Biochemistry & Molecular Biology
Cell Biology
Medicine, Research & Experimental

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites